{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:37:11Z","timestamp":1759815431646,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,12,21]]},"abstract":"<jats:p>We report a man who underwent autologous stem cell transplantation (ASCT) for multiple myeloma. Two months after ASCT, he presented with necrotising cholecystitis due to gallbladder stones and was submitted to laparoscopic cholecystectomy. About a week later, he developed progressive skin ulcers at sites where trochanters had been inserted. Progressive enlargement and necrotic aspect of these ulcers took place despite debridement and large spectrum antibiotics. New ulcers developed at the site of enoxaparin injection at the right arm (pathergy phenomenon). A skin biopsy and clinical evaluation favoured the diagnosis of pyoderma gangrenosum (PG). He was treated with daily methylprednisolone and dapsone with improvement of the lesions. This is the first case in the literature of PG after ASCT. Despite the risk factors, the onset of an autoinflammatory disease right after the transplant is intriguing since PG is extremely rare in immunocompromised patients.<\/jats:p>","DOI":"10.1136\/bcr-2017-222286","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T08:46:17Z","timestamp":1515141977000},"page":"bcr-2017-222286","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Postsurgical pyoderma gangrenosum after an autologous stem cell transplantation for multiple myeloma"],"prefix":"10.1136","volume":"2018","author":[{"given":"Maria Cecilia Borges","family":"Bittencourt","sequence":"first","affiliation":[{"name":"Department of Hematology, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-083X","authenticated-orcid":false,"given":"Marcelo Junqueira","family":"Atanazio","sequence":"additional","affiliation":[{"name":"Department of Hematology, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick Menezes","family":"Xavier","sequence":"additional","affiliation":[{"name":"Department of Hematology, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Figueiredo","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.14691","article-title":"Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation","volume":"175","author":"Marzano","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.mayocp.2016.05.001","article-title":"Postoperative Pyoderma Gangrenosum: A\u00a0Clinical Review of Published Cases","volume":"91","author":"Tolkachjov","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04201.x"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404284"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7560.181"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2958"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.9","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701361224"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02414.x"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.11","first-page":"293","article-title":"Pyoderma Gangraenosum (Dermatitis Ulcerosa) and monoclonal (IgA) globulin healed after melphalan treatment","volume":"200","author":"Moller","year":"1978","journal-title":"J Intern Med"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2169\/internalmedicine.55.5853","article-title":"Pyoderma gangrenosum in a patient with multiple myeloma","volume":"55","author":"Kikuchi","year":"2016","journal-title":"Intern Med"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.13","first-page":"168","article-title":"Symmetrical, painful ulceration of the lower limbs in a vascular surgery ward: a diagnostic challenge. Pyoderma gangrenosum associated with IgG-kappa paraproteinaemia","volume":"62","author":"Simsek","year":"2004","journal-title":"Neth J Med"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00277-009-0880-x","article-title":"Monoclonal gammopathy of undetermined significance related pyoderma gangrenosum successfully treated with autologous peripheral blood stem cell transplantation","volume":"89","author":"Chang","year":"2010","journal-title":"Ann Hematol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.15","first-page":"71","article-title":"Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice","volume":"64","author":"Kelsey","year":"2016","journal-title":"Curr Res Transl Med"},{"issue":"Suppl 98","key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.16","first-page":"53","article-title":"Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases","volume":"34","author":"Alexander","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2006.09.008"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336156"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00277-014-2277-8","article-title":"Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorder","volume":"94","author":"Shah","year":"2015","journal-title":"Ann Hematol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4103\/0971-4065.156900","article-title":"Pyoderma gangrenosum in a renal transplant recipient: A case report and review of literature","volume":"25","author":"Jha","year":"2015","journal-title":"Indian J Nephrol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.21","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/j.1432-2277.2011.01331.x","article-title":"Pyoderma gangrenosum in a renal transplantation patient having immunosuppressive treatment for 5 years","volume":"24","author":"Serdar","year":"2011","journal-title":"Transpl Int"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000251106","article-title":"Pyoderma gangrenosum in immunosuppressed patients","volume":"153","author":"Haim","year":"1976","journal-title":"Dermatologica"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2230.1989.tb02590.x","article-title":"Pyoderma gangrenosum in an allogeneic bone marrow transplant recipient","volume":"14","author":"Blanc","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"2025082723513897000_2018.jan05_1.bcr-2017-222286.24","first-page":"119","article-title":"Pyoderma gangrenosum after bone marrow transplantation for leukocyte adhesion deficiency type 1","volume":"12","author":"Elenberg","year":"2010","journal-title":"Isr Med Assoc J"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-222286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:51:48Z","timestamp":1756363908000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-222286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":24,"alternative-id":["10.1136\/bcr-2017-222286"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-222286","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}